Big Pharma Lines Up For Amarin: Healthcare Business Wrap

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Merck & Co. (NYSE:MRK) is among a number of drug firms which “would love to get their hands” on Amarin Corporation (NASDAQ:AMRN) for Vascepa, says the Daily Mail, which also says that AstraZeneca (NYSE:AZN) could be readying a cash bid for the company as well. Other big pharma companies, such as Eli Lilly and Company (NYSE:LLY), Abbott Laboratories (NYSE:ABT) and Pfizer could get into the action.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business